Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 2057

BillFederalSenateIn Committee
Pharmaceutical Regulation Conflict of Interest Act
About This Bill
Committee
Latest Action · November 1, 2017
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Congress
115th (2017–2019)
Introduced
November 1, 2017
Cosponsors (8)
8D 0R
View PDF ↗

Summary

Highlight any text to annotate
Pharmaceutical Regulation Conflict of Interest Act This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration. The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment. The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.